Research Offers for Companies
The research performed at STADIUS has various applications
![BioInformatics](imgs/bioinformatics.png)
- Diagnosis of genetics disorders
- Disease gene discovery
- Disease management
- Deep learning
- Computation methods for drug discovery
- Visual anomaly detection
- Human-in-the-loop decision support
- Privacy-preserving machine learning
- Data sharing
- Data fusion for omics and clinical data
![Biomed](imgs/biomed.png)
- Wearable Health Monitoring
- Neonatal Brain Monitoring
- Signal Processing for Next Generation Neural Implants
- EEG-fMRI Data Fusion
- EEG in Daily Life
- Cancer Diagnostics
![SMC](imgs/SMC.png)
- Data Driven modelling
- Advanced process control
- Real-life implementation
- Knowledge discovery
![DSP](imgs/DSP.png)
- Conferencing systems
- Public address systems
- 5G wireless networks
- Internet-of-Things
- Speech communication systems
- High-speed telephone line modems
- Hearing aids and Cochlear implants
- Home and car audio systems
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.